Charles J. Dockendorff has been a director of Boston Scientific since April 2015. Mr. Dockendorff was executive vice president and chief financial officer of Covidien plc, a publicly traded medical device and supplies company, and its predecessor, Tyco Healthcare, from 1995 to 2015. Mr. Dockendorff joined the Kendall Healthcare Products Company, the foundation of the Tyco Healthcare business, in 1989 as controller and was named vice president and controller in 1994. He was appointed chief financial officer of Tyco Healthcare in 1995. Prior to joining Kendall/Tyco Healthcare, Mr. Dockendorff was the chief financial officer, vice president of finance and treasurer of Epsco Inc. and Infrared Industries, Inc. Mr. Dockendorff is a director of Haemonetics Corporation, Hologic Inc., and Keysight Technologies, Inc. Mr. Dockendorff received a B.B.A in accounting from the University of Massachusetts at Amherst and a M.S. in finance from Bentley College.